3 results
The RAFT study addresses the added value of resynchronization therapy (CRT) in heart failure patients with an ICD indication and optimal pharmacological treatment. Will this result in lower mortality and less hospitalization? Results of the study…
Primary Objective:To assess the impact of TOOKAD® Soluble VTP on the rate of absence of definite cancer using patients onactive surveillance as a comparison (co-primary objective A).To determine the difference in risk of treatment failure associated…
The current trial aims to asses the safety of this combination in a phase I trial with olaparib dose escalation during two cycles of 177Lu-DOTATATE in salvage setting in patients with advanced GEP NET, progressive after initial PRRT.